October 2nd 2025
More than 1 million legally authorized workers may lose their jobs, raising new staffing and compliance challenges for independent practices.
Telehealth is effective — and potentially confusing for physicians and patients. Here’s how practices can avoid leaving patients behind.
October 1st 2025
At the MGMA Leaders Conference in Orlando, MGMA Government Affairs staff warned that a Sept. 30 lapse could stall key health extenders and deepen uncertainty. The shutdown is now here — here's what it means for physician practices.
Retroactive reimbursement, hospital at home are needed to ensure coverage during federal government shutdown.
September 30th 2025
Advocates say federal deadline, disagreement leave doctors, patients ‘dangling on the telehealth cliff.’
Trump, RFK Jr., Pfizer announce first plan to slash prescription drug prices
Savings for patients could reach 85%, and more pharmaceutical companies will have more deals to come, administration says.
How the fight over health care is going to shut down the government
Democrats want to save ACA health care subsidies and restore Medicaid funding. Republicans want a funding bill with no strings attached.
MGMA policy update for practices: Prepare for reimbursement shifts, Medicaid cuts, ACA uncertainty
At the MGMA Leaders Conference 2025 in Orlando, speakers broke down the Trump administration's effect on health policy.
Explainer: What a government shutdown would mean for you
Health care subsidies are a major point of contention for Democrats
Trump administration probes imports of medical devices, robotics and machinery for possible tariffs
Medical consumables such as syringes, sutures, catheters and gauze, as well as personal protective equipment like gloves and masks, are all receiving scrutiny.
Medicare beneficiaries face higher costs, near-universal prior authorization for GLP-1 drugs
Out-of-pocket costs for popular diabetes and weight-related medications nearly doubled in 2025, with nearly universal prior authorization requirements, according to new JAMA research.
States test new models to boost primary care spending
From Rhode Island to California, states are experimenting with ways to funnel more money into primary care, though it’s uncertain whether those investments can rein in overall health costs.
Physicians blast HHS claims about autism and acetaminophen during pregnancy
RFK Jr. targets surge in autism diagnoses with treatment, research projects.
Trump’s $100,000 H-1B fee rattles businesses and alarms physician advocates
The White House says new cost applies only to new applicants, but health care leaders warn of risks for workforce shortages.
Vaccine advocates urge ACIP to maintain public access to shots they say are saving lives
Advisory Committee on Immunization Practices sparks comments from pro-vaxxers.
ACIP holds back on vote on hepatitis B vaccines for newborns
Committee supports improving the testing levels for all pregnant women; physicians question ACIP’s analysis methods.
Primary care accounts for just 4% of U.S. health spending, HCCI report finds
Health Care Cost Institute analysis highlights shrinking investment, wide state variation and sharper rural reliance on primary care.
ACIP on COVID-19 vaccines: No prescription needed, but more warnings are
ACIP ties in vote on requiring a doctor’s order, so the committee chair broke the tie with a ‘no.’
A Medicaid model for children that saves money and improves care
Medicaid cuts threaten essential care for special needs children, risking their health and increasing costs. There is a better solution.
Why review hepatitis B vaccine at birth? It’s a question of trust, ACIP says
Advisory Committee on Immunization Practices evaluates shots as hepatitis B grows rarer in U.S. health care.
Physicians say ACIP must consider their real-world experience with patients, along with science
Physicians want a say as Advisory Committee on Immunization Practices takes up MMRV vaccine safety.
ACIP votes on change to MMRV vaccine recommendation for children younger than 4
Vaccines for Children program coverage will remain unchanged, according to vote.
ACIP: Who are the new members? Introductions in their own words
Members describe experience with vaccines, patients, research and more.
In heated times, ‘who can you trust’ on vaccines? Trust scientists willing to debate, ACIP Chair Kulldorff says
Leader of Advisory Committee on Immunization Practices offers opening statement to begin two-day meeting.
All eyes on ACIP as nation heads for ‘unknown territory’ for vaccine policies
Uncertainty builds among physicians, patients, insurers as medical groups try to fill leadership gap on vaccines.
Inflation adds $4 billion to malpractice losses, study finds
The Doctors Company warns economic and social inflation are driving higher malpractice costs, fueled by large verdicts and litigation financing.
RFK’s vaccine ideology, not evidence, led to firing, former CDC director tells senators
Susan Monarez, PhD, testifies before Senate HELP Committee.
Medicare’s new payment codes could reshape primary care, but big questions remain
A JAMA viewpoint argues new reimbursement policies may deliver long-sought revenue to primary care, though uptake, staffing and fee cuts elsewhere cloud the outlook.
HHS announces 5 new ACIP members for September meeting
Advisory Committee on Immunization Practices gets 3 physicians, pharmacist, epidemiologist.
Most parents trust core childhood vaccines, question flu and COVID shots, survey finds
New national poll highlights partisan divides and confusion as federal policy shifts under RFK Jr.’s HHS.
Advocates say rural hospitals need Rural Health Transformation Program’s $50 billion
CMS announces application details as RFK calls it ‘the largest investment ever made’ to improve rural health.
Medical practice financial viability ‘in peril’ as physician pay decreases
MGMA, Accountable for Health offer analyses of 2026 Medicare Physician Fee Schedule.
2026 Medicare reimbursement: ‘Inadequate physician payment has real-world consequences,’ AMA says
Comments published about next year’s Medicare Physician Fee Schedule.
OIG RPM data show compliance, outline enforcement priorities
CMS is at a decision point: How to improve regulation while maintaining access
Trump’s ‘most-favored nation’ drug price push: Key takeaways from our expert panel
Trump’s “most favored nation” drug pricing order could lower costs but raise new challenges for physicians, patients and pharma.